Patents Assigned to THERAPIX BIOSCIENCES LTD.
  • Publication number: 20210093652
    Abstract: Disclosed herein are pharmaceutical compositions comprising at least one anti-bacterial and at least one cannabinoid and methods of use in treating or preventing bacterial infection or biofilm in a subject in need thereof.
    Type: Application
    Filed: June 9, 2020
    Publication date: April 1, 2021
    Applicant: THERAPIX BIOSCIENCES LTD.
    Inventors: Ephraim Brener, Elran Haber, Adi Zuloff-Shani, Ascher Shmulewitz
  • Publication number: 20200038367
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: October 10, 2019
    Publication date: February 6, 2020
    Applicant: THERAPIX BIOSCIENCES, LTD.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20200030281
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: October 1, 2019
    Publication date: January 30, 2020
    Applicant: THERAPIX BIOSCIENCES, LTD.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20200022946
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: August 30, 2019
    Publication date: January 23, 2020
    Applicant: THERAPIX BIOSCIENCES, LTD.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20190183914
    Abstract: Disclosed herein are pharmaceutical compositions comprising at least one anti-bacterial and at least one cannabinoid and methods of use in treating or preventing bacterial infection or biofilm in a subject in need thereof.
    Type: Application
    Filed: January 11, 2019
    Publication date: June 20, 2019
    Applicant: THERAPIX BIOSCIENCES LTD.
    Inventors: Ephraim Brener, Elran Haber, Adi Zuloff-Shani, Ascher Shmulewitz
  • Patent number: 10000567
    Abstract: Humanized monoclonal antibodies (mAbs) or fragments thereof, to human Cluster of Differentiation 3 (CD3), which confer improved immune stimulation and stability, are disclosed. Pharmaceutical compositions comprising said mAbs and methods of treatment and optionally also prevention of diseases and disorders, such as autoimmune disorders, infectious diseases, and transplant rejection, that are susceptible to amelioration by binding to CD3, are also disclosed.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: June 19, 2018
    Assignee: Therapix Biosciences Ltd.
    Inventors: Ronald Ellis, Michael Tal, Sarit Samira, Nurit Rachamim, Timothy David Jones, Francis Joseph Carr, Shahar Dotan
  • Publication number: 20180116982
    Abstract: The present invention provides pharmaceutical compositions comprising opioids and N-acylethanolamines, and methods for their use in preventing and treating a variety of opioid-responsive conditions and opioid-related side-effects.
    Type: Application
    Filed: May 17, 2016
    Publication date: May 3, 2018
    Applicant: THERAPIX BIOSCIENCES LTD.
    Inventors: Ascher SHMULEWITZ, Elran HABER, Ephraim BRENER
  • Publication number: 20180078523
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: April 19, 2016
    Publication date: March 22, 2018
    Applicant: THERAPIX BIOSCIENCES LTD.
    Inventors: Ascher SHMULEWITZ, Elran HABER, Ephraim BRENER